R&D BIO 2024 - Live Coverage pharmaphorum is back at the BIO International Convention this year, coming to you from sunny San Diego with two days of live coverage of one of the year’s biggest pharma executive gathering
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.